{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T12:25:15Z","timestamp":1776083115733,"version":"3.50.1"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Aplasia cutis congenita (ACC) in patients with hereditary epidermolysis bullosa (EB) is often associated with major pain. We report our experience with using topical ropivacaine during dressing in newborns with ACC. Eight full-term newborns with EB and ACC were hospitalized in a neonatal intensive care unit for severe pain during dressing despite the use of paracetamol, opioids (n\u2009=\u20098) or ketamine (n\u2009=\u20097). Topical xylocaine was poorly tolerated and not effective. Ropivacaine 2\u00a0mg\/ml was used directly in contact with the ACC, with a maximum 1\u00a0mg\/kg\/day, which enabled care without the child crying. No immediate or late systemic toxicity was observed. Topical ropivacaine 0.2% appears to be an interesting topical analgesic, with good clinical tolerance and rapid action, in newborns with ACC and EB. These data need to be confirmed in a prospective study including pharmacokinetics evaluations.<\/jats:p>","DOI":"10.1186\/s13023-020-01605-3","type":"journal-article","created":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T02:02:42Z","timestamp":1606788162000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Topical ropivacaine for analgesia of aplasia cutis congenita in newborns with hereditary epidermolysis bullosa"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5382-8552","authenticated-orcid":false,"given":"A.","family":"Chambelland","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Devos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Casagrande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6063-5409","authenticated-orcid":false,"given":"C.","family":"Chiaverini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,12,1]]},"reference":[{"key":"1605_CR1","doi-asserted-by":"publisher","unstructured":": Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility. Has C. Bauer JW, C. Bodemer C, et al. Br J Dermatol. 2020. doi: https:\/\/doi.org\/10.1111\/bjd.18921.","DOI":"10.1111\/bjd.18921"},{"key":"1605_CR2","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1111\/bjd.12741","volume":"170","author":"C Chiaverini","year":"2014","unstructured":"Chiaverini C, Charlesworth A, Fernandez A, et al. Aplasia cutis congenita with dystrophic epidermolysis bullosa: clinical and mutational study. Br J Dermatol. 2014;170:901\u20136.","journal-title":"Br J Dermatol."},{"key":"1605_CR3","first-page":"211","volume":"43","author":"S Suresh","year":"2018","unstructured":"Suresh S, Ecoffey C, Bosenberg A, et al. The European Society of Regional Anaesthesia and Pain Therapy\/American Society of Regional Anesthesia and Pain Medicine Recommendations on Local Anesthetics and Adjuvants Dosage in Pediatric Regional Anesthesia. Reg Anesth Pain Med. 2018;43:211\u20136.","journal-title":"Reg Anesth Pain Med."},{"key":"1605_CR4","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1542\/peds.2004-1425","volume":"115","author":"R Carbajal","year":"2005","unstructured":"Carbajal R, Lenclen R, Jugie M, Paupe A, Barton BA, Anand KJ. Morphine does not provide adequate analgesia for acute procedural pain among preterm neonates. Pediatrics. 2005;115:1494\u2013500.","journal-title":"Pediatrics"},{"key":"1605_CR5","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/S0929-693X(97)83360-X","volume":"4","author":"R Carbajal","year":"1997","unstructured":"Carbajal R, Paupe A, Hoenn E, Lenclen R, Olivier-Martin M. DAN: une \u00e9chelle comportementale d\u2019\u00e9valuation de la douleur aigue du nouveau-n\u00e9. Arch Pediatr. 1997;4:623\u20138.","journal-title":"Arch Pediatr."},{"key":"1605_CR6","doi-asserted-by":"publisher","first-page":"1868254","DOI":"10.1155\/2018\/1868254","volume":"2018","author":"G Gasparini","year":"2018","unstructured":"Gasparini G, Saponaro G, Gasparini D, et al. The use of ropivacaine in therapeutic treatment of oral aphthosis. Biomed Res Int. 2018;2018:1868254.","journal-title":"Biomed Res Int."},{"key":"1605_CR7","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1016\/j.ijporl.2012.09.011","volume":"76","author":"M Ozkiri\u015f","year":"2012","unstructured":"Ozkiri\u015f M, Kapusuz Z, Saydam L. Comparison of ropivacaine, bupivacaine and lidocaine in the management of post-tonsillectomy pain. Int J Pediatr Otorhinolaryngol. 2012;76:1831\u20134.","journal-title":"Int J Pediatr Otorhinolaryngol."},{"key":"1605_CR8","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s00540-017-2353-z","volume":"31","author":"B Hong","year":"2017","unstructured":"Hong B, Lim CS, Kim YH, et al. Comparison of topical ropivacaine with and without ketamine on post-surgical pain in children undergoing tonsillectomy: a randomized controlled double-blind study. J Anesth. 2017;31:559\u201364.","journal-title":"J Anesth."}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-01605-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-020-01605-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-01605-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T02:04:32Z","timestamp":1606788272000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-020-01605-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":8,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1605"],"URL":"https:\/\/doi.org\/10.1186\/s13023-020-01605-3","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"14 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient\u2019s legal guardian for publication of this Letter to the Editor and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Authors do no declare conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"338"}}